Next-generation sequencing reveals altered gene expression and enriched pathways in triple-negative breast cancer cells treated with oleuropein and oleocanthal

[1]  Subash Chandra Gupta,et al.  Editorial: Targeting triple negative breast cancer by natural compounds , 2023, Frontiers in Pharmacology.

[2]  P. Magiatis,et al.  New Affordable Methods for Large-Scale Isolation of Major Olive Secoiridoids and Systematic Comparative Study of Their Antiproliferative/Cytotoxic Effect on Multiple Cancer Cell Lines of Different Cancer Origins , 2022, International journal of molecular sciences.

[3]  J. Ortega-Vidal,et al.  (-)-Oleocanthal induces death preferentially in tumor hematopoietic cells through caspase dependent and independent mechanisms. , 2022, Food & function.

[4]  Yongheng Chen,et al.  Recent advances in therapeutic strategies for triple-negative breast cancer , 2022, Journal of Hematology & Oncology.

[5]  R. Karaman,et al.  A Comprehensive Review on the Anti-Cancer Effects of Oleuropein , 2022, Life.

[6]  P. Hernández,et al.  Genome-wide exploration of oil biosynthesis genes in cultivated olive tree varieties (Olea europaea): insights into regulation of oil biosynthesis , 2022, Functional & Integrative Genomics.

[7]  Chungyeul Kim,et al.  RNA-sequencing identification and validation of genes differentially expressed in high-risk adenoma, advanced colorectal cancer, and normal controls , 2021, Functional & Integrative Genomics.

[8]  A. Siddique,et al.  Comparative Gene Signature of (−)-Oleocanthal Formulation Treatments in Heterogeneous Triple Negative Breast Tumor Models: Oncological Therapeutic Target Insights , 2021, Nutrients.

[9]  J. Ferlay,et al.  Cancer statistics for the year 2020: An overview , 2021, International journal of cancer.

[10]  J. Hull,et al.  The Anti-cancer Effect of Olea europaea L. Products: a Review , 2021, Current Nutrition Reports.

[11]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[12]  Jin-jian Lu,et al.  Natural Products in Cancer Therapy: Past, Present and Future , 2021, Natural Products and Bioprospecting.

[13]  K. Soliman,et al.  Gene Expression Alterations Associated with Oleuropein-Induced Antiproliferative Effects and S-Phase Cell Cycle Arrest in Triple-Negative Breast Cancer Cells , 2020, Nutrients.

[14]  Zeinab Amini-Farsani,et al.  The effect of oleuropein on apoptotic pathway regulators in breast cancer cells. , 2020, European journal of pharmacology.

[15]  J. Simal-Gándara,et al.  Bioactive Compounds and Quality of Extra Virgin Olive Oil , 2020, Foods.

[16]  Xiaoling Li,et al.  Predicting tumor response to drugs based on gene-expression biomarkers of sensitivity learned from cancer cell lines , 2020, BMC Genomics.

[17]  Sitanshu S. Singh,et al.  (−)-Oleocanthal as a Dual c-MET-COX2 Inhibitor for the Control of Lung Cancer , 2020, Nutrients.

[18]  A. Skaltsounis,et al.  Biomimetic Synthesis of Oleocanthal, Oleacein, and Their Analogues Starting from Oleuropein, A Major Compound of Olive Leaves. , 2020, Journal of natural products.

[19]  Yingying Xu,et al.  Metabolic Reprogramming in Triple-Negative Breast Cancer , 2020, Frontiers in Oncology.

[20]  U. Testa,et al.  Breast Cancer: A Molecularly Heterogenous Disease Needing Subtype-Specific Treatments , 2020, Medical sciences.

[21]  Dawei Li,et al.  High-Throughput Transcriptome Profiling in Drug and Biomarker Discovery , 2020, Frontiers in Genetics.

[22]  S. Bayat,et al.  The hopeful anticancer role of oleuropein in breast cancer through histone deacetylase modulation , 2019, Journal of cellular biochemistry.

[23]  M. Gnant,et al.  Breast cancer , 2019, Nature Reviews Disease Primers.

[24]  A. Siddique,et al.  Novel liquid-liquid extraction and self-emulsion methods for simplified isolation of extra-virgin olive oil phenolics with emphasis on (-)-oleocanthal and its oral anti-breast cancer activity , 2019, PloS one.

[25]  G. Salido,et al.  (-)‑Oleocanthal inhibits proliferation and migration by modulating Ca2+ entry through TRPC6 in breast cancer cells. , 2019, Biochimica et biophysica acta. Molecular cell research.

[26]  Eric P. Winer,et al.  Breast Cancer Treatment: A Review , 2019, JAMA.

[27]  A. Sureda,et al.  Oleuropein and Cancer Chemoprevention: The Link is Hot , 2017, Molecules.

[28]  Ziv Bar-Joseph,et al.  Selecting the most appropriate time points to profile in high-throughput studies , 2017, eLife.

[29]  Minoru Kanehisa,et al.  KEGG: new perspectives on genomes, pathways, diseases and drugs , 2016, Nucleic Acids Res..

[30]  M. Khanfar,et al.  Olive Oil‐derived Oleocanthal as Potent Inhibitor of Mammalian Target of Rapamycin: Biological Evaluation and Molecular Modeling Studies , 2015, Phytotherapy Research.

[31]  Parimal Ch,et al.  Use of 3D photography to measure breast volume prior to breast reconstruction , 2015 .

[32]  Daniel Spies,et al.  Dynamics in Transcriptomics: Advancements in RNA-seq Time Course and Downstream Analysis , 2015, Computational and structural biotechnology journal.

[33]  Qing-Yu He,et al.  DOSE: an R/Bioconductor package for disease ontology semantic and enrichment analysis , 2015, Bioinform..

[34]  D. A. Foster,et al.  (-)-Oleocanthal rapidly and selectively induces cancer cell death via lysosomal membrane permeabilization , 2015, Molecular & cellular oncology.

[35]  M. Stefani,et al.  Nutraceuticals and amyloid neurodegenerative diseases: a focus on natural phenols , 2015, Expert review of neurotherapeutics.

[36]  R. Keast,et al.  Oleocanthal, a Phenolic Derived from Virgin Olive Oil: A Review of the Beneficial Effects on Inflammatory Disease , 2014, International journal of molecular sciences.

[37]  M. R. Akl,et al.  Olive Phenolics as c-Met Inhibitors: (-)-Oleocanthal Attenuates Cell Proliferation, Invasiveness, and Tumor Growth in Breast Cancer Models , 2014, PloS one.

[38]  M. Elobeid,et al.  Oleuropein induces apoptosis via the p53 pathway in breast cancer cells. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[39]  A. Aboussekhra,et al.  Olive oil oleuropein has anti-breast cancer properties with higher efficiency on ER-negative cells. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[40]  E. Al-Olayan,et al.  Oleuropein induces anti-metastatic effects in breast cancer. , 2012, Asian Pacific journal of cancer prevention : APJCP.

[41]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumors , 2012, Nature.

[42]  A. Skaltsounis,et al.  Development of a green extraction procedure with super/subcritical fluids to produce extracts enriched in oleuropein from olive leaves , 2012 .

[43]  R. Fabiani,et al.  Anti-proliferative and pro-apoptotic activities of hydroxytyrosol on different tumour cells: the role of extracellular production of hydrogen peroxide , 2012, European Journal of Nutrition.

[44]  Kornelia Polyak,et al.  Heterogeneity in breast cancer. , 2011, The Journal of clinical investigation.

[45]  X. Chen,et al.  Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. , 2011, The Journal of clinical investigation.

[46]  Richard S Paules,et al.  Use of transcriptomics in understanding mechanisms of drug-induced toxicity. , 2010, Pharmacogenomics.

[47]  H. Isoda,et al.  Anti-proliferative and apoptotic effects of oleuropein and hydroxytyrosol on human breast cancer MCF-7 cells , 2009, Cytotechnology.

[48]  A. Segura‐Carretero,et al.  tabAnti-HER2 (erbB-2) oncogene effects of phenolic compounds directly isolated from commercial Extra-Virgin Olive Oil (EVOO) , 2008, BMC Cancer.

[49]  A. Segura‐Carretero,et al.  Olive oil's bitter principle reverses acquired autoresistance to trastuzumab (Herceptin™) in HER2-overexpressing breast cancer cells , 2007, BMC Cancer.

[50]  Kanyawim Kirtikara,et al.  Sulforhodamine B colorimetric assay for cytotoxicity screening , 2006, Nature Protocols.

[51]  V. Polzonetti,et al.  Involvement of oleuropein in (some) digestive metabolic pathways , 2004 .

[52]  G. Peters,et al.  Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing. , 1991, European journal of cancer.

[53]  Rajdeep Chowdhury,et al.  Analysis of Transcriptomic Data Generated from Drug-Treated Cancer Cell Line. , 2022, Methods in molecular biology.

[54]  M. D'Archivio,et al.  Extra virgin olive oil polyphenols: biological properties and antioxidant activity , 2020 .

[55]  Pascale Gaudet,et al.  The Gene Ontology , 2019, Encyclopedia of Bioinformatics and Computational Biology.

[56]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumours , 2013 .

[57]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[58]  H. Iwase,et al.  [Breast cancer]. , 2006, Nihon rinsho. Japanese journal of clinical medicine.

[59]  B Marshall,et al.  Gene Ontology Consortium: The Gene Ontology (GO) database and informatics resource , 2004, Nucleic Acids Res..

[60]  Gene Ontology Consortium.  The Gene Ontology (GO) database and informatics resource , 2003 .